Quince Therapeutics, Inc. (QNCX)
Market Open
15 Jun, 14:15
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 95
+0.02
+2.1527%
$
5.2M Market Cap
- P/E Ratio
- Div Yield
58,167 Volume
0 Eps
$ 0.93
Previous Close Analysts:
Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JK Jason Kolbert D. Boral Capital | -24,375.15 | $32,336.67 | $23,156.39 | $9,180.28 | 28.39% |
